0001209191-20-032004.txt : 20200526 0001209191-20-032004.hdr.sgml : 20200526 20200526162029 ACCESSION NUMBER: 0001209191-20-032004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200521 FILED AS OF DATE: 20200526 DATE AS OF CHANGE: 20200526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lacey David L. CENTRAL INDEX KEY: 0001734422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38419 FILM NUMBER: 20910801 MAIL ADDRESS: STREET 1: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcus Biosciences, Inc. CENTRAL INDEX KEY: 0001724521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473898435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 694-6200 MAIL ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-21 0 0001724521 Arcus Biosciences, Inc. RCUS 0001734422 Lacey David L. C/O 3928 POINT EDEN WAY HAYWARD CA 94545 1 0 0 0 Stock Option (right to buy) 36.34 2020-05-21 4 A 0 50000 0.00 A 2030-05-20 Common Stock 50000 50000 D The option is exercisable in 36 equal monthly installments after May 21, 2020, subject to the Reporting Person's continued service to the Company. /s/ Carolyn Tang, Attorney-in-Fact 2020-05-26